MoneyWorks4Me

Neuland Laboratories informs about analyst presentation

01 Aug 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Neuland Laboratories has informed that it enclosed the presentation to the Investors/ Analysts on the Financial Results of the Company for the quarter ended June 30, 2024. The presentation is also being uploaded on the website of the Company at www.neulandlabs.com.

The above information is a part of company’s filings submitted to BSE.




Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..